KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $3.4 billion.

  • Cvs Health's Cash from Operations rose 8225.81% to $3.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.6 billion, marking a year-over-year increase of 1682.22%. This contributed to the annual value of $10.6 billion for FY2025, which is 1682.22% up from last year.
  • Latest data reveals that Cvs Health reported Cash from Operations of $3.4 billion as of Q4 2025, which was up 8225.81% from $796.0 million recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Cash from Operations registered a high of $9.1 billion during Q3 2022, and its lowest value of -$2.6 billion during Q4 2023.
  • Over the past 5 years, Cvs Health's median Cash from Operations value was $3.5 billion (recorded in 2022), while the average stood at $3.4 billion.
  • Per our database at Business Quant, Cvs Health's Cash from Operations crashed by 14873.91% in 2022 and then soared by 20684.56% in 2025.
  • Quarter analysis of 5 years shows Cvs Health's Cash from Operations stood at $4.0 billion in 2021, then crashed by 148.74% to -$2.0 billion in 2022, then tumbled by 35.04% to -$2.6 billion in 2023, then soared by 170.56% to $1.9 billion in 2024, then surged by 82.26% to $3.4 billion in 2025.
  • Its last three reported values are $3.4 billion in Q4 2025, $796.0 million for Q3 2025, and $1.9 billion during Q2 2025.